Integer Holdings Corporation (NYSE:ITGR - Get Free Report) shares hit a new 52-week low during mid-day trading on Friday . The company traded as low as $99.54 and last traded at $100.23, with a volume of 197658 shares traded. The stock had previously closed at $103.40.
Analysts Set New Price Targets
A number of equities analysts have recently issued reports on ITGR shares. Raymond James Financial dropped their target price on Integer from $150.00 to $143.00 and set an "outperform" rating for the company in a report on Friday, July 25th. Truist Financial dropped their price target on Integer from $145.00 to $137.00 and set a "buy" rating for the company in a report on Friday, July 25th. Wells Fargo & Company lowered their target price on Integer from $152.00 to $132.00 and set an "overweight" rating for the company in a research note on Friday, July 25th. Wall Street Zen raised Integer from a "hold" rating to a "buy" rating in a research note on Saturday, August 30th. Finally, Weiss Ratings reissued a "hold (c)" rating on shares of Integer in a research note on Wednesday. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and two have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $139.57.
Get Our Latest Research Report on Integer
Integer Trading Down 3.3%
The company has a fifty day simple moving average of $105.31 and a two-hundred day simple moving average of $113.74. The stock has a market capitalization of $3.50 billion, a P/E ratio of 44.11, a price-to-earnings-growth ratio of 0.83 and a beta of 0.97. The company has a quick ratio of 2.18, a current ratio of 3.41 and a debt-to-equity ratio of 0.72.
Integer (NYSE:ITGR - Get Free Report) last released its quarterly earnings results on Thursday, July 24th. The medical equipment provider reported $1.55 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.57 by ($0.02). The firm had revenue of $476.00 million during the quarter, compared to analyst estimates of $464.37 million. Integer had a net margin of 4.61% and a return on equity of 12.27%. The business's revenue for the quarter was up 11.4% compared to the same quarter last year. During the same period in the prior year, the business earned $1.30 EPS. Integer has set its FY 2025 guidance at 6.250-6.510 EPS. On average, sell-side analysts expect that Integer Holdings Corporation will post 6.01 earnings per share for the current year.
Institutional Trading of Integer
Several large investors have recently modified their holdings of ITGR. Alliancebernstein L.P. grew its holdings in shares of Integer by 885.1% during the 2nd quarter. Alliancebernstein L.P. now owns 1,106,091 shares of the medical equipment provider's stock worth $136,016,000 after purchasing an additional 993,810 shares in the last quarter. Vaughan Nelson Investment Management L.P. bought a new stake in Integer during the first quarter worth $33,337,000. Nuveen LLC bought a new stake in Integer during the first quarter worth $17,634,000. Millennium Management LLC lifted its stake in Integer by 2,408.8% during the first quarter. Millennium Management LLC now owns 123,132 shares of the medical equipment provider's stock worth $14,531,000 after purchasing an additional 118,224 shares during the last quarter. Finally, Viking Global Investors LP lifted its stake in Integer by 9.1% during the second quarter. Viking Global Investors LP now owns 1,283,965 shares of the medical equipment provider's stock worth $157,889,000 after purchasing an additional 106,692 shares during the last quarter. 99.29% of the stock is owned by institutional investors and hedge funds.
Integer Company Profile
(
Get Free Report)
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Integer, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Integer wasn't on the list.
While Integer currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.